Plain-English translation of NCT03299569 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is trying to understand how often Takotsubo cardiomyopathy — a temporary heart condition that can feel like a heart attack — occurs in Scotland. Researchers will gather medical records from all patients diagnosed with this condition since 2010 and compare their outcomes to people who had actual heart attacks and to the general population. The goal is to create a complete picture of who gets this condition and how it affects them over time.
Takotsubo cardiomyopathy is a rare heart condition that doctors don't yet fully understand, including how common it really is or how it compares to other heart problems. By collecting and analyzing medical data from many patients across Scotland, researchers hope to learn more about this condition so they can better diagnose and treat people in the future.
You likely qualify if…
You likely don't qualify if…
If you are enrolled, the research team will access your existing medical records from Scottish health services — you won't need to attend visits or undergo new tests. Researchers will use your medical data that has already been collected and stored in the health system, comparing your health outcomes and any medications you've taken to other patients' records. This is a retrospective and ongoing study, meaning some data will come from your past medical history and some may continue to be collected as you receive regular care.
AI-generated summary from trial data · Oct 5, 2026 · Not medical advice
United Kingdom
Collaborators
NHS Tayside, NHS Lothian
Enrollment target
~800 participants
Started
July 2016
Primary completion
December 2028
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dana Dawson, MD, MRCP
University of Aberdeen
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.